Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vinorelbine Plus Gemcitabine (VG) Versus Vinorelbine Plus Carboplatin (VC) in Advanced Non-small Cell Lung Cancer. An Open Randomized Multicenter Phase III Trial From Norwegian Lung Cancer Study Group (NLCG)

NCT00737867 is registered in ClinicalTrials.gov with The Norwegian Lung Cancer Study Group as lead sponsor.

NCT NCT00737867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00737867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vinorelbine Plus Gemcitabine (VG) Versus Vinorelbine Plus Carboplatin (VC) in Advanced Non-small Cell Lung Cancer. An Open Randomized Multicenter Phase III Trial From Norwegian Lung Cancer Study Group (NLCG)
Lead sponsor
The Norwegian Lung Cancer Study Group
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
February 28, 2011
Enrollment
444 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

advanced non-small cell lung cancer